Suchergebnisse - "Esfahani, Ensieh Nasli"

PubPharm (5)

1

Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents : In vitro α-glucosidase inhibition, kinetic, and docking study

enthalten in: Bioorganic chemistry | 2019

von Saeedi, M. | Mohammadi-Khanaposhtani, M. | Pourrabia, P. | +11

2

Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled study

enthalten in: Nutrition research (New York, N.Y.) | 2018

von Khodabandehloo, H. | Seyyedebrahimi, S. | Esfahani, E. | +2

3

Diabetes in Iran : Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)

enthalten in: Scientific reports | 2017

von Esteghamati, A. | Larijani, B. | Aghajani, M. | +13

4

Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus

enthalten in: Menopause (New York, N.Y.) | 2016

von Razi, F. | Esmaili, M. | Esfahani, E. | +6

5

Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production

enthalten in: Cytokine | 2015

von Mazloom, H. | Alizadeh, S. | Pasalar, P. | +2

1
[1]